Beryl Therapeutics
PrivateLast Round
Grant
May 18, 2023
Total Funding Raised
$250,000
Company Overview
Beryl Therapeutics operates in Healthcare & Life Sciences and is based in Longmont, Colorado. Its latest recorded funding round was a Grant round in May 2023.
Beryl Therapeutics is a biotechnology company that develops patented small molecule therapies to increase bone mass and treat bone diseases such as osteoporosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beryl Therapeutics Comparables
Compare Beryl Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skeletalis Bio | 80% | |
| Mesentech Inc. | 80% | |
| Aptacure Therapeutics Limited | 76% |
For institutional investors. Book with your work email.
Beryl Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Beryl Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Prader-Willi Research | Seed |
| Advanced Industries Accelerator Program | Grant |
Beryl Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beryl Therapeutics's valuation, stock price, and market status.
Is Beryl Therapeutics a public or private company?
Beryl Therapeutics is a private company.
What is the current stock price of Beryl Therapeutics?
Beryl Therapeutics is a private company, so its shares have no public market price. Caplight tracks Beryl Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beryl Therapeutics worth (valuation)?
Valuation information for Beryl Therapeutics is not publicly available.
Can I buy Beryl Therapeutics stock?
Beryl Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beryl Therapeutics's last funding round?
Beryl Therapeutics's most recent funding round was Grant on May 18, 2023.
Who are the main investors in Beryl Therapeutics?
Key investors in Beryl Therapeutics include Foundation for Prader-Willi Research, Advanced Industries Accelerator Program.
Will Beryl Therapeutics IPO soon?
No public IPO plans have been announced for Beryl Therapeutics.
How can I track Beryl Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Beryl Therapeutics's shares on secondary markets.